Skip to main content
BJA Education logoLink to BJA Education
. 2024 May 31;24(9):343. doi: 10.1016/j.bjae.2024.04.001

Corrigendum to ‘Non-regional analgesia for labour: remifentanil in obstetrics’ [BJA Education 19 (2019) 357–61]

I Ronel 1,, CF Weiniger 1
PMCID: PMC11368589  PMID: 39234157

The authors regret that errors were present on page 359, under the heading ‘Remifentanil compared with fentanyl’, sub-section ‘Safety’. The correct paragraph should read:

Safety

There were significantly higher sedation scores and a higher frequency of maternal desaturations amongst women receiving remifentanil compared with fentanyl. Conversely, neonatal Apgar scores were lower (<7 at 1 min for 39% compared with 18%) and the need for resuscitation (bag-and-mask ventilation or tracheal intubation) was greater (59% compared with 25%) when fentanyl was used, compared with remifentanil.

In summary:

(i) Evidence suggests that remifentanil provides better pain relief than fentanyl.

(ii) More frequent maternal desaturations and respiratory depression, and greater sedation occurs using remifentanil compared with fentanyl.

(iii) There are lower neonatal Apgar scores and greater need for positive-pressure ventilation with fentanyl compared with remifentanil

The authors apologise for any inconvenience caused.


Articles from BJA Education are provided here courtesy of Elsevier

RESOURCES